BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//OTRADI - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.otradi.org
X-WR-CALDESC:Events for OTRADI
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210120T150000
DTEND;TZID=America/Los_Angeles:20210120T160000
DTSTAMP:20210111T222724Z
CREATED:20210111T221154Z
LAST-MODIFIED:20210111T222724Z
UID:10000277-1611154800-1611158400@www.otradi.org
SUMMARY:ULP Event: Market Access and Life Cycle Aspects of Medical Technology Products
DESCRIPTION:Interactive event about the lifecycle stages of medical devices and IVD. \nThis interactive event will provide an overview of the respective stages of the Lifecycle of a Medical Device and IVD\, from the early patent stages through development\, regulatory\, clinical and commercial aspects\, to exit strategies. \nEvent Speaker \nJaap Laufer\nMedical Director\, Emergo Group\nDr. Jaap Laufer has over 30 years of medical device regulatory experience and specializes in implant and high-risk device submissions\, FDA QSR compliance\, and clinical study approvals and compliance. Jaap’s background includes: clinical study consulting for implants\, combination\, and high-risk devices; global clinical regulatory strategy and pre-study meetings with FDA\, CAs and NBs; protocol development\, site selection\, and approvals\, including actual CRF monitoring and CRA work (heart valves)\, study report evaluation and review; pre-IDE negotiations with the FDA; and resolution of FDA warning letters. As Medical Director\, Jaap is an expert reviewer of clinical data and evidence for novel and high-risk devices. In his additional capacity as senior clinical consultant\, he also peer reviews EU Technical File submissions\, and assists with Notified Body selection and classification. Prior to Emergo by UL\, he held executive and senior regulatory positions at Pfizer\, Abbott Laboratories\, LipoMatrix\, and others. He has been a visiting professor for International Regulatory Affairs at the University of Southern California since 2005 and is a permanent member of the Medical Device Experts Group (MDEG) for classification to the EU Commission. Jaap holds an MD from the Medical School of the University of Nijmegen and a Doctor of Pharmacy from the University of Groningen\, both in The Netherlands.
URL:https://www.otradi.org/event/ulp-event-market-access-and-life-cycle-aspects-of-medical-technology-products/
LOCATION:OR\, United States
CATEGORIES:Partner Programs/Events
END:VEVENT
END:VCALENDAR